Avory & Company’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
Avory & Company's OMCL Position: Q3 2026 in Review
Avory & Company reduced its Omnicell (OMCL) stake by 12% in Q3 2026, selling an estimated $302K and leaving 58,702 shares worth $2M. The position accounts for 2.53% of the portfolio, ranked #12.
Avory & Company first reported a position in OMCL in Q4 2020 and has held it in 24 quarters since. The position peaked at $19.5M in Q4 2020. 305 funds tracked by Wall St. Rank hold OMCL as of Q3 2026.
- Avory & Company held 58,702 shares of Omnicell worth $2M as of Q3 2026.
- Avory & Company sold 8,028 Omnicell shares in Q3 2026, an estimated $302K.
- Omnicell made up 2.53% of Avory & Company's portfolio in Q3 2026, its #12 holding.
- Avory & Company first reported a position in Omnicell in Q4 2020 and has held it in 24 quarters since.
- Avory & Company's Omnicell position peaked at $19.5M in Q4 2020.
- 305 funds tracked by Wall St. Rank held Omnicell as of Q3 2026.
Based on Avory & Company's 13F filing for Q3 2026, filed 21 Oct 2026.